Curriculum-Based Online and Live Activities


Course Director
Naval Daver, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Curriculum Description

Effective AML management is increasingly characterized by an ability to differentiate between disease subtypes and determine which molecular features, such as relevant baseline mutations, can establish a prognosis and potentially guide therapy selection in conjunction with other factors (such as age and treatment setting). Recently, new evidence on the efficacy and safety of emerging novel therapeutic options has emerged, including for molecularly targeted agents, cytotoxic therapies, epigenetic treatments, and newer antibodies, among other approaches; these innovative strategies will likely play a larger role in the more personalized care of patients with AML.

This curriculum will offer hematology-oncology professionals an expert-led guide to the changing landscape of AML management, and feature a diverse collection of practical strategies to allow for the increased development and use of more effective and personalized treatment options in AML. To learn more, join Dr. Naval Daver for this engaging educational activity, and then register to have one of our experts join you on-site for an interactive discussion.

Target Audience

The activity will be designed to meet the educational needs of hematologists, oncologists, oncology nurses, and other clinicians involved in the management of patients with AML.